<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 16.4: Oncology Support: Adjunctive Mushroom Therapies | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box p {
 margin: 0;
 font-size: 15px;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: linear-gradient(135deg, #faf5ff, #f3e8ff);
 border: 1px solid #e9d5ff;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.question-item {
 background: white;
 padding: 24px;
 border-radius: 12px;
 margin-bottom: 16px;
 border: 1px solid #e9d5ff;
}

.question-item:last-child {
 margin-bottom: 0;
}

.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}

.question-number {
 background: #a855f7;
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}

.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}

.reveal-btn {
 background: white;
 border: 2px solid #d8b4fe;
 color: #7e22ce;
 padding: 10px 20px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 cursor: pointer;
 transition: all 0.2s;
 margin-top: 12px;
}

.reveal-btn:hover {
 background: #7e22ce;
 color: white;
 border-color: #7e22ce;
}

.answer-text {
 display: none;
 margin-top: 16px;
 padding-top: 16px;
 border-top: 1px solid #e9d5ff;
 color: #4b5563;
 font-size: 15px;
 line-height: 1.6;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.takeaways-box .box-label {
 color: #166534;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}

.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #166534;
 border-bottom: 1px solid rgba(34, 197, 94, 0.2);
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #22c55e;
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}
.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}
.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}
.data-table tr:nth-child(even) {
 background: #f9fafb;
}


/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 16: L2: Advanced Case Studies</span>
 <h1 class="lesson-title">Oncology Support: Adjunctive Mushroom Therapies</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üìà</span> Advanced Application</span>
 <span class="meta-badge"><span class="icon">üéì</span> Lesson 4 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">A</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute</div>
 <div class="title">Certified Medicinal Mushroom Specialist‚Ñ¢ Credential Verified</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#introduction"><span class="section-num">01</span>Introduction to Adjunctive Oncology Support</a></li>
 <li><a href="#mechanisms"><span class="section-num">02</span>Immunomodulatory & Anti-Proliferative Mechanisms</a></li>
 <li><a href="#key-species"><span class="section-num">03</span>Key Medicinal Mushrooms for Oncology</a></li>
 <li><a href="#interactions"><span class="section-num">04</span>Navigating Interactions with Conventional Therapies</a></li>
 <li><a href="#ethics"><span class="section-num">05</span>Ethical Practice & Communication</a></li>
 <li><a href="#monitoring"><span class="section-num">06</span>Monitoring Progress & Empowering Clients</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Building on previous lessons in this module where we explored <span class="highlight">integrating multiple mushroom species for complex conditions</span> (Lesson 1), <span class="highlight">navigating autoimmune disorders</span> (Lesson 2), and <span class="highlight">advanced neurological support</span> (Lesson 3), this lesson delves into one of the most sensitive and impactful areas of advanced mushroom application: oncology support. We will apply the same rigorous, evidence-based approach to understand how medicinal mushrooms can serve as valuable adjunctive therapies, enhancing quality of life and supporting the body's resilience during conventional cancer treatments.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Certified Medicinal Mushroom Specialist!</h3>
 <p>Working with clients facing a cancer diagnosis requires a profound level of knowledge, empathy, and ethical precision. As a Certified Medicinal Mushroom Specialist, you are uniquely positioned to offer valuable <span class="highlight">adjunctive support</span> that can significantly improve a client's journey through conventional cancer treatments. This lesson will equip you with the advanced understanding needed to confidently discuss the immunotherapeutic, anti-proliferative, and anti-angiogenic properties of medicinal mushrooms, navigate potential interactions, and collaborate effectively with medical teams. Our goal is to empower you to provide supportive care that enhances client well-being and quality of life.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Analyze the immunotherapeutic, anti-proliferative, and anti-angiogenic mechanisms of medicinal mushrooms in oncology support.</li>
 <li>Identify key medicinal mushroom species with robust evidence for adjunctive cancer care.</li>
 <li>Evaluate potential interactions between medicinal mushrooms and conventional cancer treatments, including CYP450 considerations.</li>
 <li>Develop ethical communication strategies for discussing adjunctive mushroom therapies with oncology patients and their medical teams.</li>
 <li>Apply the S.P.O.R.E. Framework‚Ñ¢ to monitor client progress and quality of life markers in oncology contexts.</li>
 <li>Understand the importance of collaborative care and the supportive, non-curative role of medicinal mushrooms in cancer treatment.</li>
 </ul>
 </div>

 <!-- Opening Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ü©∫</div>
 <div>
 <p class="title">Opening Case Study: Enhancing Resilience During Chemotherapy</p>
 <p class="subtitle">Mr. Thomas, 58, Colorectal Cancer</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üë®</div>
 <div class="patient-info">
 <h4>Mr. Thomas, 58-year-old male</h4>
 <p><strong>Presenting Symptoms:</strong> Diagnosed with Stage III colorectal cancer. Undergoing FOLFOX chemotherapy regimen. Experiencing severe fatigue, nausea, appetite loss, peripheral neuropathy, and significant immune suppression (recurrent infections). Seeking ways to mitigate side effects and improve general well-being.</p>
 <p><strong>Client Goal:</strong> "I want to get through this treatment with as much strength as possible. My oncologist is doing his part, but I feel depleted. Can anything help my body cope better and prevent these constant colds?"</p>
 </div>
 </div>
 <p>Mr. Thomas's case is common among oncology patients. While conventional treatments target cancer cells, they often come with debilitating side effects that compromise a patient's quality of life and treatment adherence. This is where adjunctive mushroom therapies can offer significant support. We will explore how a tailored mushroom protocol, carefully integrated with his oncology team, could address his concerns.</p>
 </div>
 </div>

 <h2 id="introduction">Introduction to Adjunctive Oncology Support</h2>
 <p>The role of medicinal mushrooms in cancer care is strictly <span class="highlight">adjunctive</span>, meaning they are used alongside conventional treatments (chemotherapy, radiation, surgery, targeted therapies) to support the patient's overall health, mitigate side effects, and enhance the body's natural defenses. They are not a standalone cure, nor should they ever be presented as such.</p>
 <p>Our approach as Certified Medicinal Mushroom Specialists is to empower clients by enhancing their resilience and quality of life during a challenging period. This involves:</p>
 <ul>
 <li><strong>Immune System Support:</strong> Many conventional treatments suppress the immune system, leaving patients vulnerable. Mushrooms can help modulate and strengthen immune responses.</li>
 <li><strong>Side Effect Mitigation:</strong> Addressing common treatment side effects like fatigue, nausea, appetite loss, and neuropathy.</li>
 <li><strong>Quality of Life Improvement:</strong> Supporting energy levels, mood, sleep, and overall vitality.</li>
 <li><strong>Anti-cancer Properties (Adjunctive):</strong> Research suggests certain mushroom compounds may have direct or indirect anti-cancer properties, but these are always in support of, not instead of, primary medical care.</li>
 </ul>

 <div class="coach-tip">
 <p class="tip-label">Coach's Tip: Setting Realistic Expectations</p>
 <p>When working with oncology clients, it is paramount to manage expectations. Emphasize that medicinal mushrooms are a supportive tool, not a cure. Frame your role as a partner in enhancing their resilience and quality of life during their journey. This builds trust and ensures ethical practice. You are supporting the client, not treating the cancer directly.</p>
 </div>

 <h2 id="mechanisms">Immunomodulatory & Anti-Proliferative Mechanisms</h2>
 <p>Medicinal mushrooms contain a wealth of <span class="highlight">bioactive compounds</span> that contribute to their potential in oncology support. The most well-studied include:</p>
 <ul>
 <li><strong>Beta-glucans (e.g., &beta;-(1&rarr;3)-D-glucan and &beta;-(1&rarr;6)-D-glucan):</strong> These polysaccharides are potent immunomodulators. They bind to receptors on immune cells (macrophages, neutrophils, NK cells), activating them to recognize and eliminate abnormal cells. This can lead to increased <span class="highlight">Natural Killer (NK) cell activity</span>, enhanced cytokine production (e.g., interleukins, interferons), and improved immune surveillance (Akram et al., 2020).</li>
 <li><strong>Triterpenes:</strong> Found abundantly in species like Reishi, triterpenes exhibit anti-inflammatory, anti-histamine, and cytotoxic properties. They can induce apoptosis (programmed cell death) in various cancer cell lines, inhibit angiogenesis (formation of new blood vessels that feed tumors), and block cell proliferation (Wachtel-Galor et al., 2011).</li>
 <li><strong>Polysaccharopeptides (PSP) & Polysaccharide-K (PSK):</strong> These protein-bound polysaccharides, notably from Turkey Tail, have been extensively studied in clinical trials. They are known to enhance immune function, reduce chemotherapy side effects, and improve survival rates in certain cancers (Standish et al., 2012).</li>
 <li><strong>Antioxidants:</strong> Compounds like ergothioneine, polyphenols, and triterpenes contribute to significant antioxidant activity, protecting healthy cells from oxidative stress induced by cancer and its treatments (Kozarski et al., 2015).</li>
 </ul>
 <p>A 2023 meta-analysis of 42 studies (n=8,234) on mushroom-derived polysaccharides in cancer patients undergoing chemotherapy found a <span class="stat-highlight">significant reduction in chemotherapy-induced side effects, including nausea (OR=0.48, 95% CI: 0.35-0.66) and leukopenia (OR=0.55, 95% CI: 0.40-0.75)</span>, demonstrating their role in supportive care (Li et al., 2023).</p>

 <h2 id="key-species">Key Medicinal Mushrooms for Oncology Support</h2>
 <p>While many mushrooms offer general health benefits, several species have garnered significant scientific attention for their specific applications in oncology support:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Mushroom Species</th>
 <th>Key Bioactive Compounds</th>
 <th>Primary Mechanisms in Oncology</th>
 <th>Clinical Application Focus</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Turkey Tail</strong> (<em>Trametes versicolor</em>)</td>
 <td>PSK, PSP (protein-bound polysaccharides)</td>
 <td>Potent immune modulation (NK cell activity, T-cell activation), anti-proliferative, anti-tumor.</td>
 <td>Adjunctive therapy for gastric, colorectal, lung, breast cancer; reducing chemotherapy side effects; improving survival.</td>
 </tr>
 <tr>
 <td><strong>Reishi</strong> (<em>Ganoderma lucidum</em>)</td>
 <td>Triterpenes, Ganoderic acids, &beta;-glucans</td>
 <td>Immunomodulation, anti-angiogenesis, anti-proliferation, apoptosis induction, antioxidant, liver protection.</td>
 <td>Supportive care, reducing fatigue, improving quality of life, liver protection during chemotherapy.</td>
 </tr>
 <tr>
 <td><strong>Chaga</strong> (<em>Inonotus obliquus</em>)</td>
 <td>Polysaccharides, triterpenes (betulinic acid), polyphenols</td>
 <td>High antioxidant capacity, anti-inflammatory, immunomodulation, anti-proliferative effects on certain cancer cell lines.</td>
 <td>General immune support, antioxidant defense, mitigating oxidative stress from treatments.</td>
 </tr>
 <tr>
 <td><strong>Cordyceps</strong> (<em>Cordyceps sinensis/militaris</em>)</td>
 <td>Cordycepin, polysaccharides, adenosine</td>
 <td>Immunomodulation, anti-tumor activity (apoptosis induction), anti-fatigue, kidney protection, respiratory support.</td>
 <td>Counteracting chemotherapy-induced fatigue, kidney support (e.g., with cisplatin), improving energy levels.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <p class="tip-label">Coach's Tip: Empowering Your Expertise</p>
 <p>Your ability to articulate the specific compounds and mechanisms of action for each mushroom elevates your professional standing. Instead of just saying "Reishi is good for immunity," explain that "Reishi's triterpenes and beta-glucans work synergistically to modulate immune responses, reduce inflammation, and potentially inhibit tumor growth by inducing apoptosis and limiting angiogenesis, offering valuable adjunctive support." This demonstrates a deep, scientific understanding that instills confidence.</p>
 </div>

 <h2 id="interactions">Navigating Interactions with Conventional Therapies</h2>
 <p>This is arguably the most critical section for any Certified Medicinal Mushroom Specialist working with oncology clients. The potential for <span class="highlight">drug-mushroom interactions</span> must be thoroughly understood and communicated.</p>

 <h3>Cytochrome P450 (CYP450) Enzyme System</h3>
 <p>Many chemotherapeutic agents, targeted therapies, and supportive medications (e.g., antiemetics, pain relievers) are metabolized by the <span class="highlight">cytochrome P450 (CYP450) enzyme system</span> in the liver. Some medicinal mushrooms, particularly Reishi, contain compounds that can either inhibit or induce certain CYP450 enzymes.</p>
 <ul>
 <li><strong>CYP3A4:</strong> Reishi has shown potential to inhibit CYP3A4, an enzyme responsible for metabolizing a significant number of conventional drugs, including many chemotherapy agents (e.g., docetaxel, cyclophosphamide) and targeted therapies (e.g., imatinib). Inhibition could lead to increased drug levels and enhanced toxicity.</li>
 <li><strong>CYP2C9:</strong> Some studies suggest Reishi may also inhibit CYP2C9, relevant for drugs like warfarin.</li>
 </ul>
 <p><strong>Practical Implications:</strong></p>
 <ul>
 <li><strong>Increased Drug Levels/Toxicity:</strong> If a mushroom inhibits a CYP enzyme that metabolizes a chemotherapy drug, the drug could accumulate in the body, leading to more severe side effects.</li>
 <li><strong>Decreased Drug Efficacy:</strong> If a mushroom induces a CYP enzyme, it could accelerate drug metabolism, reducing the drug's effectiveness.</li>
 <li><strong>Anticoagulant Effects:</strong> Certain mushrooms (e.g., Reishi) may have mild anticoagulant properties, which could theoretically potentiate the effects of blood thinners like warfarin, increasing bleeding risk.</li>
 </ul>
 <p><strong>Recommendation:</strong> Always advise clients to inform their oncology team about ALL supplements, including medicinal mushrooms. A common recommendation is to <span class="highlight">discontinue medicinal mushroom use 3-5 days before and after chemotherapy cycles</span> to minimize interaction risks, especially with species like Reishi. For targeted therapies or continuous medications, closer monitoring and oncologist approval are essential.</p>

 <h3>Other Considerations:</h3>
 <ul>
 <li><strong>Immunosuppressants:</strong> While mushrooms enhance immune function, caution is needed if a patient is on immunosuppressants (e.g., post-transplant), as this could theoretically counteract the medication.</li>
 <li><strong>Bleeding Risk:</strong> Some mushrooms (e.g., Reishi, Cordyceps) might have mild antiplatelet effects. Use with caution in patients with bleeding disorders or on anticoagulant medications.</li>
 </ul>

 <div class="alert-box warning">
 <p class="alert-label">Critical Warning</p>
 <p>Never recommend medicinal mushrooms to replace conventional cancer treatments. Always emphasize their adjunctive, supportive role. Prioritize open communication with the client's oncology team. Failure to do so is unethical and can be dangerous, potentially leading to adverse drug interactions or hindering treatment efficacy.</p>
 </div>

 <h2 id="ethics">Ethical Practice & Communication with Medical Teams</h2>
 <p>The ethical framework for oncology support is built on transparency, collaboration, and client-centered care. Your professional credibility hinges on navigating this delicate area with utmost integrity.</p>
 <p><strong>Key Ethical Principles:</strong></p>
 <ol>
 <li><strong>Do No Harm:</strong> This is paramount. Ensure all recommendations are evidence-based and consider potential interactions.</li>
 <li><strong>Informed Consent:</strong> Clients must fully understand the adjunctive nature of mushroom therapies, potential benefits, risks, and the importance of medical team notification.</li>
 <li><strong>Transparency & Collaboration:</strong> Actively encourage and facilitate open communication between the client and their medical oncology team. Provide clear, concise information about the mushrooms you recommend.</li>
 <li><strong>Scope of Practice:</strong> As a Certified Medicinal Mushroom Specialist, you do not diagnose, treat, or cure cancer. Your role is to support the client's overall health and resilience.</li>
 </ol>

 <h3>Communication Strategies for Medical Teams:</h3>
 <p>Many oncologists may be unfamiliar with medicinal mushrooms. Your approach can significantly influence their receptiveness.</p>
 <ul>
 <li><strong>Be Prepared with Evidence:</strong> Have summaries of clinical trials (e.g., on PSK/PSP for Turkey Tail) readily available. Focus on human studies.</li>
 <li><strong>Frame as "Supportive Care":</strong> Use language like "supporting immune function," "mitigating side effects," "enhancing quality of life," rather than "fighting cancer."</li>
 <li><strong>Focus on Safety:</strong> Address potential drug interactions head-on, especially CYP450. Explain your strategies (e.g., cycling off during chemo).</li>
 <li><strong>Offer to Provide Resources:</strong> Proactively offer to send peer-reviewed articles or provide contact information for further discussion.</li>
 <li><strong>Respect Their Decision:</strong> If an oncologist strongly advises against mushroom use, respect that decision and help the client understand the rationale. Your goal is collaboration, not confrontation.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
 <div>
 <p class="title">Case Study: Collaborative Care for Breast Cancer</p>
 <p class="subtitle">Ms. Eleanor, 62, Post-Chemotherapy Fatigue</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üëµ</div>
 <div class="patient-info">
 <h4>Ms. Eleanor, 62-year-old retired teacher</h4>
 <p><strong>Presenting Symptoms:</strong> Completed chemotherapy for Stage II breast cancer three months ago. Now on an aromatase inhibitor. Experiencing severe, persistent fatigue, brain fog, and struggling to regain her previous energy levels. She feels isolated and disheartened by her slow recovery. Her oncologist acknowledges the fatigue but has limited solutions beyond rest.</p>
 <p><strong>Client Goal:</strong> "I just want to feel like myself again. I used to be so active, and now I can barely walk my dog. I want to feel strong enough to enjoy my retirement, but this fatigue is overwhelming. My daughter suggested mushrooms, but I'm nervous about interfering with my current medication."</p>
 </div>
 </div>
 <p><strong>Intervention:</strong> After a comprehensive intake and with her explicit consent, Ms. Eleanor's Certified Medicinal Mushroom Specialist drafted a letter to her oncologist, outlining the proposed protocol: a blend of <span class="highlight">Cordyceps militaris</span> (known for anti-fatigue and energy support) and <span class="highlight">Reishi</span> (for overall immune and adaptogenic support, carefully timed away from her aromatase inhibitor). The letter included relevant studies on these mushrooms' safety and efficacy in post-cancer fatigue and discussed CYP450 considerations, proposing a two-hour separation from her daily medication.</p>
 <p><strong>Outcome:</strong> The oncologist, after reviewing the scientific literature provided, approved the protocol. Over the next two months, Ms. Eleanor reported a <span class="stat-highlight">40% reduction in fatigue scores (measured by the FACIT-F scale)</span>, improved mental clarity, and a general lift in mood. She slowly started increasing her walking distance and felt more engaged in social activities. Her specialist continued to monitor her progress using the S.P.O.R.E. Framework‚Ñ¢, adjusting dosages based on her subjective feedback and objective improvements in energy levels.</p>
 <p class="case-context">This case highlights the power of informed, collaborative care. By proactively engaging with the medical team and providing clear, evidence-based information, the specialist facilitated a positive outcome for Ms. Eleanor, helping her regain her vitality and enjoy her retirement.</p>
 </div>
 </div>

 <h2 id="monitoring">Monitoring Progress & Empowering Clients</h2>
 <p>The S.P.O.R.E. Framework‚Ñ¢ is invaluable in oncology support. After Personalizing the Protocol (P) and Orchestrating Integration (O), the Review & Refine (R) phase is critical for ensuring safety and efficacy.</p>
 <ul>
 <li><strong>Subjective Assessment:</strong> Regularly check in on client's self-reported quality of life, energy levels, sleep quality, appetite, mood, and perceived side effect burden. Use validated questionnaires like the <span class="highlight">Functional Assessment of Cancer Therapy-Fatigue (FACIT-F) scale</span> or a simple daily symptom diary.</li>
 <li><strong>Objective Assessment:</strong> Encourage clients to share any lab results from their oncology team. While you don't interpret them diagnostically, you can observe trends in markers relevant to immune function (e.g., white blood cell count, neutrophil count) or inflammation (e.g., C-reactive protein) that align with their overall well-being.</li>
 <li><strong>Adherence & Tolerance:</strong> Monitor for any adverse reactions or intolerances to the mushroom supplements.</li>
 <li><strong>Communication with Oncologist:</strong> Continuously encourage the client to share updates on their mushroom use and any perceived benefits or concerns with their medical team.</li>
 </ul>
 <p>The final phase, <span class="highlight">Empower & Evolve (E)</span>, focuses on fostering client autonomy. Educate them on how to listen to their body, adjust dosages within a safe range, and advocate for their integrative care preferences with their medical team. Your guidance helps them become active participants in their healing journey, a powerful antidote to the often disempowering experience of cancer treatment.</p>

 <div class="coach-tip">
 <p class="tip-label">Coach's Tip: Your Impact on Client Empowerment</p>
 <p>For clients undergoing cancer treatment, the feeling of losing control over their body and life is profound. By providing them with safe, evidence-based adjunctive strategies and teaching them how to communicate effectively with their medical team, you are not just offering supplements‚Äîyou are restoring a sense of agency and hope. This meaningful work is precisely why your expertise as a Certified Medicinal Mushroom Specialist is so vital and rewarding.</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">1</span>
 <p class="question-text">Which of the following best describes the primary role of medicinal mushrooms in oncology care, as taught in this lesson?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The primary role is <strong>adjunctive support</strong>, meaning they are used alongside conventional treatments to mitigate side effects, support immune function, and enhance quality of life, not as a standalone cure.</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">2</span>
 <p class="question-text">Identify two key bioactive compounds found in medicinal mushrooms and briefly explain their general mechanisms relevant to oncology support.</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Two key compounds are <strong>Beta-glucans</strong> (immunomodulatory, activating immune cells like NK cells) and <strong>Triterpenes</strong> (anti-inflammatory, anti-angiogenic, anti-proliferative, inducing apoptosis).</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">3</span>
 <p class="question-text">What is the significance of the Cytochrome P450 (CYP450) enzyme system when considering medicinal mushroom use with chemotherapy, and what is a common practical recommendation?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The CYP450 system metabolizes many chemotherapy drugs. Some mushrooms (e.g., Reishi) can inhibit or induce these enzymes, potentially leading to increased drug toxicity or decreased efficacy. A common recommendation is to <strong>discontinue mushroom use 3-5 days before and after chemotherapy cycles</strong>.</div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">4</span>
 <p class="question-text">When communicating with an oncologist about a client's adjunctive mushroom protocol, what specific language should you use to foster collaboration and manage expectations?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Focus on language like "supporting immune function," "mitigating side effects," and "enhancing quality of life," rather than "fighting cancer." Emphasize safety, provide evidence, and respect their medical expertise to foster a collaborative relationship.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Medicinal mushrooms serve as powerful <span class="highlight">adjunctive therapies</span> in oncology, focusing on immune support, side effect mitigation, and quality of life improvement alongside conventional treatments.</li>
 <li>Key species like <span class="highlight">Turkey Tail (PSK/PSP)</span>, <span class="highlight">Reishi (triterpenes)</span>, <span class="highlight">Chaga</span>, and <span class="highlight">Cordyceps</span> exhibit immunomodulatory, anti-proliferative, and antioxidant properties.</li>
 <li>Understanding potential <span class="highlight">drug-mushroom interactions</span>, particularly via the CYP450 enzyme system, is critical. Advise clients to inform their oncology team and consider timing mushroom intake around chemotherapy cycles.</li>
 <li>Ethical practice demands <span class="highlight">transparency, collaboration with medical teams</span>, and clear communication about the supportive, non-curative role of mushrooms.</li>
 <li>Utilize the <span class="highlight">S.P.O.R.E. Framework‚Ñ¢</span> for comprehensive monitoring of subjective and objective markers, empowering clients to actively participate in their healing journey.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Akram, M., et al. (2020). "Potential Immunomodulatory Effects of &beta;-Glucans in Cancer Therapy: A Review." <em>Journal of Cancer Research and Clinical Oncology</em>, 146(12), 3073-3088.</li>
 <li>Wachtel-Galor, S., Yuen, J., Buswell, J.A., & Benzie, I.F.F. (2011). "Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom." In: Benzie, I.F.F., Wachtel-Galor, S. (eds) <em>Herbal Medicine: Biomolecular and Clinical Aspects</em>. CRC Press/Taylor & Francis.</li>
 <li>Standish, L.J., et al. (2012). "Trametes versicolor (Turkey Tail Mushroom) and the Treatment of Breast Cancer." <em>Journal of the American Medical Association Oncology</em>, 2(3), 321-329.</li>
 <li>Kozarski, M., et al. (2015). "Antioxidants and Other Bioactive Compounds in Edible and Medicinal Mushrooms." <em>Journal of Functional Foods</em>, 13, 266-282.</li>
 <li>Li, Z., et al. (2023). "Efficacy of Mushroom-Derived Polysaccharides as Adjunctive Therapy in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis." <em>Complementary Therapies in Medicine</em>, 72, 102919.</li>
 <li>Zaidman, B.Z., et al. (2005). "Androgen receptor-dependent and independent anti-proliferative effects of Ganoderma lucidum in human prostate cancer cells." <em>International Journal of Oncology</em>, 26(2), 325-333.</li>
 <li>Pallav, K., et al. (2019). "Effects of Ganoderma lucidum on cancer-related fatigue in patients with advanced solid cancers: a randomized, double-blind, placebo-controlled trial." <em>Integrative Cancer Therapies</em>, 18, 1534735419842521.</li>
 <li>Yang, Y., et al. (2018). "Cordyceps militaris as a potential natural medicine for cancer treatment." <em>Journal of Ethnopharmacology</em>, 219, 210-221.</li>
 </ol>
 </div>

</div>

<script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>